Microbial ColonizationNCT07045636
Microbiome Modulation by PEMF on Plaque Induced Mucositis in Human Jaws
A study testing Teeth wih gingivits in people with Microbial Colonization and Peri-Implantitis, run by Jamil awad shibli at 1 site in Brazil.
Trial summary
To evaluate the impact of Pulsed Electromagnetic Field (PEMF) on mucositis induced in humans around dental implants and correlate these possible effects with the proteomic profile of implants with and without PEMF and teeth. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Microbial Colonization, Peri-Implantitis
- What is being tested?
- Teeth wih gingivits
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 35 participants
- Where
- 1 siteBrazil
- Study dates
- 11 May 2025to 11 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Inclusion Criteria: -healthy individuals over 18 years of age
- have at least 2 contiguous edentulous spaces
- more than 15 teeth
- have not undergone periodontal treatment for at least 6 months before the start of the study
Exclusion Criteria: - Individuals with extensive dental restorations;
- with periodontal disease stages II to IV
- with peri-implantitis and/or mucositis (Shibli et al. 2015);
- individuals requiring previous grafting for implant insertion;
- diabetics;
- smokers or former smokers;
- pregnant women; lactating women;
- use of antibiotics or oral antiseptics in the last 6 months .
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Microbial Modulation by PEMF on Paque Induced Mucositis in Dental Implants Placed in Human Jaws: Microbiome and Proteomic Analysis.
To evaluate the impact of Pulsed Electromagnetic Field (PEMF) on mucositis induced in humans around dental implants and correlate these possible effects with the proteomic profile of implants with and without PEMF and teeth. The hypothesis is that PEMF may modulate bacterial biofilm formation around dental implants and enhance the host response following plaque-induced peri-implant mucositis. Secondary analysis will be the increase in the soft tissue volume using Intra-oral scanning (IOS).
Read the detailed description
As in natural teeth, bacterial colonization of the implant surface can trigger a reversible inflammatory process in the peri-implant soft tissue-defined mucositis. However, differences in the organization of peri-implant tissues may combat the progression of lesions associated with bacterial biofilm, resulting in a broader inflammatory infiltrate compared to periodontal tissues. Some previous studies have used electromagnetic pulses (PEMF-pulse electromagnetic fields) to modulate bacterial biofilm. Thus, the objective of this study will be to evaluate the host response pattern (proteomics, microbiome, and clinical) during the induction and progression of experimental gingivitis and mucositis in humans with the action of the electromagnetic pulse. Forty systemically healthy individuals will be included, who must present the need for two implant-supported restorations adjacent to the teeth. Individuals will receive oral hygiene instruction and professional prophylaxis fortnightly, 30 days before implant installation. The implants will be installed in time -60 days. After 60 days, at baseline, the healing abutment will be installed on the two implants, one conventional and the other with an electromagnetic pulse. At the same time, everyone will receive acetate plates to protect the selected areas (tooth and implants) during brushing, to be used for 21 days. Clinical periodontal parameters, microbiological (supragingival and subgingival biofilm), and immunological (crevicular fluid) collections will be obtained at 0, 3, 7, 14, 21, 42, and 60 days. IOS will be performed in all the periods. The results will be evaluated for normality using the D'Agostino test. Then, parametric or non-parametric tests will be applied to compare the means/medians obtained between the gingivitis and mucositis groups in the different periods of the study.
- Conditions
- Microbial Colonization, Peri-Implantitis
- Being tested
- PEMF abd Sham (control), Teeth wih gingivits
- Keywords
- dental implants, peri-implantitis, mucositis, microbiome, proteomic
- Medical subject headings
- Communicable Diseases, Peri-Implantitis, Mucositis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PEMF abd Sham (control)Other
Dental implants receive MED that could (test) or could not (control/SHAM) be activated to emit PEMF
Teeth wih gingivitsDiagnostic test
Comparison with dental implants
| Study group | Role | What they receive |
|---|---|---|
| PEMF x Control (without PEMF) | Experimental | Test group - Activated MED (with PEMF) installed on the test implants during the 21 days
Control group - Non-activated MED (without PEMF) installed and NOT activated on the control implants during 21 days Receives: Other: PEMF abd Sham (control); Diagnostic Test: Teeth wih gingivits |
| Dental implants x teeth | No intervention | Comparison between tooth and implants (with and without PEMF) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of clusters of microorganism
amount of genera and microbial species detected and/or altered (reduction and increase)
Measured: time points 0, 3, 6, 7, 14, 21, 28, 42, and 60 days
Secondary outcomes (1)
Increase on the soft tissue volume using IOS
Overlapping images according to each period
Measured: time points 0, 3, 6, 7, 14, 21, 28, 42, and 60 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2025
- Study start11 May 2025
- Primary completion11 May 2025
- Study completion11 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Microbial ColonizationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Control group (healing cap without PEMF); test group with PEMF Comparison with teeth x implants (with or without PEMF)
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 35 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jamil awad shibli
- Sponsor type
- University, hospital or other
- Collaborators
- Harvard School of Dental Medicine, Hospital Israelita Albert Einstein
- Responsible party
- Sponsor-investigator, Jamil awad shibli, University of Guarulhos
- Investigators
- Jamil A Shibli, PhD, Principal investigator, Guarulhos UniversityCinthya Massari, DDS, Study director, Guarulhos University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07045636
- Sponsor's protocol ID
- PEMF and mucositis
- Status last verified
- Apr 2026
- First submitted
- 15 May 2025
- Last updated
- 1 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Souza JGS, Azevedo F, Borges MHR, Costa RC, Shiba T, Barak S, Mayer Y, Figueiredo LC, Feres M, Barao VAR, Shibli JA. Microbiome modulation of implant-related infection by a novel miniaturized pulsed electromagnetic field device. NPJ Biofilms Microbiomes. 2025 Feb 26;11(1):36. doi: 10.1038/s41522-025-00667-0.
PubMed 40011461Parize G, Luana Jimenez G, Shibli JA, Siroma R, Caetano MW, Kim YJ, Braz-Silva PH, da Silva Martinho H, Pallos D. Evaluation of Peri-Implantitis through Fourier-Transform Infrared Spectroscopy on Saliva. J Proteome Res. 2025 Feb 7;24(2):639-648. doi: 10.1021/acs.jproteome.4c00707. Epub 2025 Jan 10.
PubMed 39792796Mayer Y, Shibli JA, Saada HA, Melo M, Gabay E, Barak S, Ginesin O. Pulsed Electromagnetic Therapy: Literature Review and Current Update. Braz Dent J. 2024 Oct 25;35:e246109. doi: 10.1590/0103-6440202406109. eCollection 2024.
PubMed 39476109Mayer Y, Khoury J, Horwitz J, Ginesin O, Canullo L, Gabay E, Giladi HZ. A novel nonsurgical therapy for peri-implantitis using focused pulsed electromagnetic field: A pilot randomized double-blind controlled clinical trial. Bioelectromagnetics. 2023 Oct-Dec;44(7-8):144-155. doi: 10.1002/bem.22481. Epub 2023 Sep 1.
PubMed 37655846Faveri M, Miquelleto DEC, Bueno-Silva B, Pingueiro JMS, Figueiredo LC, Dolkart O, Yakobson E, Barak S, Feres M, Shibli JA. Antimicrobial effects of a pulsed electromagnetic field: an in vitro polymicrobial periodontal subgingival biofilm model. Biofouling. 2020 Aug;36(7):862-869. doi: 10.1080/08927014.2020.1825694. Epub 2020 Sep 29.
PubMed 32993357
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Microbial Modulation by PEMF on Paque Induced Mucositis in Dental Implants Placed in Human Jaws: Microbiome and Proteomic Analysis.
- ClinicalTrials.gov ID
- NCT07045636
- Acronym / sponsor ID
- PEMF and mucositis
- Conditions
- Microbial Colonization, Peri-Implantitis
- Keywords
- dental implants, peri-implantitis, mucositis, microbiome, proteomic
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 35 participants (actual)
- Lead sponsor
- Jamil awad shibliUniversity, hospital or other
- Collaborators
- Harvard School of Dental Medicine, Hospital Israelita Albert Einstein
- Study start
- 11 May 2025 (actual)
- Primary completion
- 11 May 2025 (actual)
- Study completion
- 11 May 2025 (actual)
- First posted
- 1 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the impact of Pulsed Electromagnetic Field (PEMF) on mucositis induced in humans around dental implants and correlate these possible effects with the proteomic profile of implants with and without PEMF and teeth. The hypothesis is that PEMF may modulate bacterial biofilm formation around dental implants and enhance the host response following plaque-induced peri-implant mucositis. Secondary analysis will be the increase in the soft tissue volume using Intra-oral scanning (IOS).
Detailed description
As in natural teeth, bacterial colonization of the implant surface can trigger a reversible inflammatory process in the peri-implant soft tissue-defined mucositis. However, differences in the organization of peri-implant tissues may combat the progression of lesions associated with bacterial biofilm, resulting in a broader inflammatory infiltrate compared to periodontal tissues. Some previous studies have used electromagnetic pulses (PEMF-pulse electromagnetic fields) to modulate bacterial biofilm. Thus, the objective of this study will be to evaluate the host response pattern (proteomics, microbiome, and clinical) during the induction and progression of experimental gingivitis and mucositis in humans with the action of the electromagnetic pulse. Forty systemically healthy individuals will be included, who must present the need for two implant-supported restorations adjacent to the teeth. Individuals will receive oral hygiene instruction and professional prophylaxis fortnightly, 30 days before implant installation. The implants will be installed in time -60 days. After 60 days, at baseline, the healing abutment will be installed on the two implants, one conventional and the other with an electromagnetic pulse. At the same time, everyone will receive acetate plates to protect the selected areas (tooth and implants) during brushing, to be used for 21 days. Clinical periodontal parameters, microbiological (supragingival and subgingival biofilm), and immunological (crevicular fluid) collections will be obtained at 0, 3, 7, 14, 21, 42, and 60 days. IOS will be performed in all the periods. The results will be evaluated for normality using the D'Agostino test. Then, parametric or non-parametric tests will be applied to compare the means/medians obtained between the gingivitis and mucositis groups in the different periods of the study.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Control group (healing cap without PEMF); test group with PEMF Comparison with teeth x implants (with or without PEMF)
| Arm | Type | Receives |
|---|---|---|
| PEMF x Control (without PEMF) | Experimental | Other: PEMF abd Sham (control), Diagnostic Test: Teeth wih gingivitsTest group - Activated MED (with PEMF) installed on the test implants during the 21 days Control group - Non-activated MED (without PEMF) installed and NOT activated on the control implants during 21 days |
| Dental implants x teeth | No intervention | –Comparison between tooth and implants (with and without PEMF) |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PEMF abd Sham (control)Dental implants receive MED that could (test) or could not (control/SHAM) be activated to emit PEMF | Other | PEMF x Control (without PEMF) |
| Teeth wih gingivitsComparison with dental implants | Diagnostic test | PEMF x Control (without PEMF) |
Primary outcome
Number of clusters of microorganism
Time frame: time points 0, 3, 6, 7, 14, 21, 28, 42, and 60 days
amount of genera and microbial species detected and/or altered (reduction and increase)
1 secondary outcome
Increase on the soft tissue volume using IOS
Time frame: time points 0, 3, 6, 7, 14, 21, 28, 42, and 60 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2026.
- Background: PubMed 40011461Souza JGS, Azevedo F, Borges MHR, Costa RC, Shiba T, Barak S, Mayer Y, Figueiredo LC, Feres M, Barao VAR, Shibli JA. Microbiome modulation of implant-related infection by a novel miniaturized pulsed electromagnetic field device. NPJ Biofilms Microbiomes. 2025 Feb 26;11(1):36. doi: 10.1038/s41522-025-00667-0.
- Background: PubMed 39792796Parize G, Luana Jimenez G, Shibli JA, Siroma R, Caetano MW, Kim YJ, Braz-Silva PH, da Silva Martinho H, Pallos D. Evaluation of Peri-Implantitis through Fourier-Transform Infrared Spectroscopy on Saliva. J Proteome Res. 2025 Feb 7;24(2):639-648. doi: 10.1021/acs.jproteome.4c00707. Epub 2025 Jan 10.
- Background: PubMed 39476109Mayer Y, Shibli JA, Saada HA, Melo M, Gabay E, Barak S, Ginesin O. Pulsed Electromagnetic Therapy: Literature Review and Current Update. Braz Dent J. 2024 Oct 25;35:e246109. doi: 10.1590/0103-6440202406109. eCollection 2024.
- Background: PubMed 37655846Mayer Y, Khoury J, Horwitz J, Ginesin O, Canullo L, Gabay E, Giladi HZ. A novel nonsurgical therapy for peri-implantitis using focused pulsed electromagnetic field: A pilot randomized double-blind controlled clinical trial. Bioelectromagnetics. 2023 Oct-Dec;44(7-8):144-155. doi: 10.1002/bem.22481. Epub 2023 Sep 1.
- Background: PubMed 32993357Faveri M, Miquelleto DEC, Bueno-Silva B, Pingueiro JMS, Figueiredo LC, Dolkart O, Yakobson E, Barak S, Feres M, Shibli JA. Antimicrobial effects of a pulsed electromagnetic field: an in vitro polymicrobial periodontal subgingival biofilm model. Biofouling. 2020 Aug;36(7):862-869. doi: 10.1080/08927014.2020.1825694. Epub 2020 Sep 29.
- Individual participant dataSharing planned: No
Related trials for Microbial Colonization
RecruitingObservational study
A Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute Pharyngitis
Streptococcal Pharyngitis, Group A Streptococcal Infection
Active, not recruitingPhase 3
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
Pneumococcal Disease
Enrolling by invitation
Evaluating the Efficacy of Annual CHTC Retesting Among Male Couples at High Risk of HIV Infection
HIV Infections
RecruitingPhase 1/2
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Tuberculosis
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jamil A Shibli, PhD principal investigator
Guarulhos University
Cinthya Massari, DDS study director
Guarulhos University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Teeth wih gingivits in people with Microbial Colonization and Peri-Implantitis, run by Jamil awad shibli at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of clusters of microorganism (time frame: time points 0, 3, 6, 7, 14, 21, 28, 42, and 60 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07045636, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.